Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of
Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No.:
36197T103
1. Names of Reporting Persons:
M&G Investment Management Limited
No I.R.S.
Identification Number
2. Check the Appropriate Box if a Member of a Group (See Instructions
)
3. SEC Use Only
4. Citizenship or Place of Organization:
United Kingdom, England
Number of Shares Beneficially Owned By Each Reporting Person With:
5. Sole Voting Power:
20,800,044
6. Shared
Voting Power
: 0
7. Sole Dispositive Power:
20,800,044
8. Shared Dispositive Power:
0
9. Aggregate
Amount Beneficially Owned by Each Reporting Person:
20,800,044
10. Check if the Aggregate Amount in Row (9) Excludes Certain
Shares (See Instructions) ☐
11. Percent of Class Represented by Amount in Row (9):
6.88%
12. Type of Reporting Person (See Instructions):
IA
2
CUSIP No.:
36197T103
1. Names of Reporting Persons:
M&G Investment Funds (3)
No I.R.S Identification
Number
2. Check the Appropriate Box if a Member of a Group (See Instructions)
3. SEC Use Only
4. Citizenship or Place of Organization:
United Kingdom, England
Number of Shares Beneficially Owned By Each Reporting Person With:
5. Sole Voting Power:
0
6. Shared Voting
Power:
0
7. Sole Dispositive Power:
0
8. Shared Dispositive Power:
0
9. Aggregate
Amount Beneficially Owned by Each Reporting Person:
19,380,000
10. Check if the Aggregate Amount in Row (9) Excludes Certain
Shares (See Instructions) ☐
11. Percent of Class Represented by Amount in Row (9):
6.41%
12. Type of Reporting Person (See Instructions):
IV
3
Item 1.
(a)
|
Name of Issuer:
GW Pharmaceuticals
Plc
|
(b)
|
Address of Issuers Principal Executive Offices:
Sovereign House, Vision Park, Chivers Way, Histon,
Cambridge, CB24 9BZ United Kingdom
|
(a)
|
Name of Person Filing:
|
M&G Investment Management Limited
M&G Investment Funds (3)
(b)
|
Address of Principal Business Office or, if none, Residence:
Governors House, Laurence Pountney Hill,
London, EC4R 0HH
|
(c)
|
Citizenship:
United Kingdom, England
|
(d) Title of Class of Securities:
American Depositary Receipt
(e) CUSIP Number:
36197T103
Item 3.
If this statement is filed pursuant to
§§240.13d-1(b)
or
240.13d-2(b)
or (c), check whether the person filing is a:
|
|
|
(a) ☐
|
|
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
|
(b) ☐
|
|
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
|
(c) ☐
|
|
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
|
(d) ☐
|
|
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).
|
(e) ☒
|
|
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
|
(f) ☐
|
|
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
|
(g) ☐
|
|
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
|
(h) ☐
|
|
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.
1813);
|
(i) ☐
|
|
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment
Company Act of 1940 (15 U.S.C. 80a-3);
|
(j) ☐
|
|
A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J).
|
(k) ☐
|
|
Group, in accordance with §240.13d-1(b)(1)(ii)(K).
|
(e) MAGIM is an investment adviser in accordance with
s.240.13d-1(b)(1)(ii)(E)
All the securities covered by this report are legally owned by
MAGIMs Investment advisory clients, and none are directly owned by MAGIM. M&G Investment Funds (3) is an open ended investment company with variable capital, incorporated in England and Wales and authorized by the Financial Conduct
Authority. It is not registered with the Securities Exchange Commission under the Investment Company Act of 1940.
4
Item 4. Ownership.
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
M&G Investment Management Limited
(a) Amount beneficially owned:
20,800,044
(b) Percent of class:
6.88%
(
c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
20,800,044
(ii) Shared power to vote or to direct the vote:
0
(iii) Sole power to dispose or to direct the disposition of:
20,800,044
(iv) Shared power to dispose or to direct the disposition of:
0
M&G Investment Funds (3)
(a) Amount beneficially owned:
19,380,000
(b) Percent of class:
6.41%
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
0
(ii) Shared power to vote or to direct the vote:
0
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
0
Item 5. Ownership of Five Percent or Less of a Class
Not Applicable.
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Not Applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding
Company
Not Applicable.
Item 8. Identification and Classification of Members of the Group
Not Applicable.
Item 9. Notice of Dissolution of Group
Not Applicable.
Item 10. Certification
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the
ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a
participant in any transaction having that purpose or effect.
5
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: 02/2018
M&G Investment Management Limited
|
|
|
Name: James Todd
|
Title: Shareholder Disclosures Senior Analyst
|
M&G Investment Funds (3)
|
|
|
Name: James Todd
|
Title: Shareholder Disclosures Senior Analyst
|
6
EXHIBIT INDEX
|
|
|
|
|
Ex.
|
|
|
|
Page No.
|
|
|
|
A.
|
|
Joint Filing Agreement
|
|
8
|
7
EXHIBIT A
JOINT FILING AGREEMENT
The undersigned hereby agree that the statement on Schedule 13G with respect to Common Stock of
GW Pharmaceuticals Plc
dated as of
31
December 2017
is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule
13d-1(k)
under the Securities Exchange Act of 1934, as amended.
Date: 02/2018
M&G Investment Management Limited
|
|
|
By:
|
|
/s/ James Todd
|
|
|
Name: James Todd
|
|
|
Title: Shareholder Disclosures Senior Analyst
|
M&G Investment Funds (3)
|
|
|
By:
|
|
/s/ James Todd
|
|
|
Name: James Todd
|
|
|
Title: Shareholder Disclosures Senior Analyst
|
8